Personal Genome Diagnostics, Inc.

Personal Genome Diagnostics (PGDx) is a leader in cancer genomics, focused on empowering personalized cancer care through rapid and accurate genomic testing. They offer a comprehensive portfolio of tissue-based and liquid biopsy genomic products, including their flagship elio™ platform. The elio™ platform features automated bioinformatics, enabling laboratories to perform comprehensive genomic profiling (CGP) in-house, reducing turnaround times and providing more timely results for patients. PGDx is committed to making CGP testing readily available, driving precision oncology forward and ensuring all patients have access to best-in-class genomic testing.

PGDx has a strong academic foundation, having been established by researchers from Johns Hopkins University, pioneers in cancer genome sequencing and liquid biopsy technologies. Their expertise in genomics has led to numerous collaborations with leading academic medical centers, hospitals, and pharmaceutical companies. PGDx’s dedication to innovation is evident in their ongoing development of new technologies and applications, ensuring their products remain at the forefront of precision oncology. The company is now a subsidiary of Labcorp, a leading global life sciences company, further expanding their reach and resources in the fight against cancer.

Personal Genome Diagnostics (PGDx) is dedicated to advancing precision oncology by providing rapid and comprehensive genomic profiling (CGP) solutions, empowering healthcare professionals with actionable insights to guide personalized cancer care for all patients. Their mission is to remove barriers to precision oncology testing, making timely and personalized cancer treatments a reality for everyone.

Personal Genome Diagnostics (PGDx) promotes a culture focused on empowering personalized cancer care and advancing precision oncology. They value innovation, collaboration, and a commitment to making a difference in the lives of patients. The company's website highlights their mission, dedication to scientific excellence, and a sense of purpose in their work, which is reflected in the stories shared by employees. The emphasis on accessibility and rapid results suggests a fast-paced environment with a drive to deliver impactful solutions.